Hoey Investments, Inc Moderna, Inc. Transaction History

Hoey Investments, Inc

$524 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 22, 2024	BUY	$96.41 - $126.61 $26,705 - $35,070	277 Added 25.51%	1,363 $140,000
Q3 2023 Oct 23, 2023	BUY	$96.41 - $126.61 $26,705 - $35,070	277 Added 25.51%	1,363 $140,000
Q2 2023 Apr 22, 2024	SELL	$118.5 - $160.53 $53,325 - $72,238	-450 Reduced 29.3%	1,086 $131,000
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $53,325 - $72,238	-450 Reduced 29.3%	1,086 $131,000
Q1 2023 Apr 22, 2024	BUY	$135.66 - $197.02 $208,373 - $302,622	1,536 New	1,536 $235,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $54,264 - $78,808	-400 Reduced 20.66%	1,536 $235,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $53,271 - $94,518	-450 Reduced 18.86%	1,936 $347,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $147,587 - $242,725	1,250 Added 110.04%	2,386 $282,000
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $7,496 - $11,301	-64 Reduced 5.33%	1,136 $162,000
Q1 2022 Apr 25, 2022	BUY	$126.46 - $235.05 $52,354 - $97,310	414 Added 52.67%	1,200 $207,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.84 Million - $6.27 Million	-17,009 Reduced 95.58%	786 $200,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.09 Million - $2.38 Million	4,903 Added 38.03%	17,795 $6.85 Million
Q2 2021 Nov 12, 2021	BUY	$129.91 - $234.98 $1.65 Million - $2.98 Million	12,672 Added 5760.0%	12,892 $3.03 Million
Q1 2021 Nov 12, 2021	BUY	$109.18 - $185.98 $21,836 - $37,196	200 Added 1000.0%	220 $29,000
Q4 2020 Jan 22, 2021	SELL	$65.74 - $169.86 $1,314 - $3,397	-20 Reduced 50.0%	20 $2,000
Q2 2020 Jul 10, 2020	BUY	$29.67 - $80.0 $1,186 - $3,200	40 New	40 $3,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoey Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hoey Investments, Inc with notifications on news.

Account